Table 3 Univariate and multivariate analysis showing the DFS rate for ovarian cancer patients
From: Jumonji domain-containing 6 (JMJD6) identified as a potential therapeutic target in ovarian cancer
Variables | Univariate analysis | Multivariate analysis | ||||
|---|---|---|---|---|---|---|
RR | 95% CI | P value | RR | 95% CI | P value | |
JMJD6: % of stained cells | 2.783 | 1.769–4.377 | <0.001 | 1.385 | 0.812–2.364 | 0.232 |
Age | 1.032 | 1.012–1.052 | 0.001 | 1.008 | 0.988–1.029 | 0.433 |
pT status | 0.09 | 0.033–0.246 | <0.001 | 0.107 | 0.027–0.425 | 0.001 |
pN status | 5.698 | 3.587–9.053 | <0.001 | 1.178 | 0.605–2.295 | 0.63 |
pM status | 6.276 | 3.849–10.233 | <0.001 | 2.449 | 1.242–4.831 | 0.01 |
Tumor diameter | 0.935 | 0.426–2.054 | 0.868 | 0.777 | 0.344–1.757 | 0.545 |
Pathological grade | 0.352 | 0.086–1.44 | 0.146 | 2.876 | 0.519–15.923 | 0.226 |
